Raphaël G. Ognar, MSc MBA
Senior Vice-President Global Oncology/Hematology Solutions, Alira Health
President, CEO & Co-Founder, NKILT Therapeutics
Pharma/Biotech executive with 24 years of commercial, drug development, product lifecycle and strategy expertise, with about 20 years in Oncology.
Throughout his career, he built extensive expertise in Oncology/Hematology and acquired leadership skills through multiple country and global roles in commercial, pipeline management and drug development, and strategy. For the last decade, he increased his focus on Immuno-Oncology and Cell Therapy technologies.
In 2018 he created ANIM8 LLC, an executive strategy and operations consulting company, where he focused essentially on supporting early-stage Biotechs, essentially in Immuno-Oncology and Cell Therapy, but also Digital Health / RWE startups.
Since Summer 2021, Raphaël founded NKILT Therapeutics and is building with his co-founders the evidence to bring a new allogeneic cell therapy concept based on an innovative binding approach.
In March 2022, he joined Alira Health, as SVP Global Oncology/Hematology and C> Solutions, to contribute to this fast growing and disrupting health services company, with the aim to humanize healthcare through a full spectrum of patient-centric data and tech-enabled services.
Besides fighting cancer, his passions are vintage wines, playing music in his family band, pushing himself rock climbing and traveling the world with friends and family.
Raphaël owns a Master and a D.E.A. of Physiology and Neurosciences from University of Bordeaux I&II, and an MBA in Strategic Marketing and Enterprise Management from I.A.E of Tours University.
Key areas of expertise
- Drug development
- Product lifecycle and strategy